project id: TCGA-STAD; case submitter id: TCGA-D7-A4YX; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 9.3; age at index: 63; days to birth: -23249; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23249; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1108.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 197; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-D7-A4YX-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 2.0; percent necrosis: 12.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 28.0; percent tumor cells: 60.0; percent tumor nuclei: 65.0;